Laiba Immad

Contributing Author

Recent Articles by Laiba Immad

Jun-06	Sanofi (SNY) Stock Down 5% Despite AERIFY-1 Success SNY Insider Monkey
May-30	Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 AVDL Insider Monkey
May-30	Concord Medical Services Holdings Limited (CCM)'s Subsidiary Debuts Nation's First Proton Therapy LLM CCM Insider Monkey
May-29	Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025 CSTL Insider Monkey
May-29	FDA Grants Orphan Drug Status to Beam Therapeutics Inc. (BEAM)' AATD Gene Therapy BEAM Insider Monkey
May-29	Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis ILMN Insider Monkey
May-29	Health Net and Centene Corporation (CNC) Commit Over $7.2 Million to Boost Healthcare Access Through Mobile Clinics in California CNC Insider Monkey
May-29	Morgan Stanley Lifts Performance Food Group Company (PFGC) Stock Target to $93 PFGC Insider Monkey
May-29	Silexion Therapeutics Corp (SLXN)'s RNAi Therapy Blocks 90% of Colorectal Tumors SLXN Insider Monkey
May-29	Candel Therapeutics, Inc. (CADL)'s CAN-2409 Advances with FDA RMAT Status for Localized Prostate Cancer CADL Insider Monkey
May-29	Cytek Biosciences, Inc. (CTKB) Elevates Cell Analysis with New Aurora Evo System CTKB Insider Monkey
May-29	Gyre Therapeutics, Inc. (GYRE) Raises $23M in Public Stock Offering to Fund Liver Fibrosis Trials GYRE Insider Monkey
May-29	Atlantic International Corp. (ATLN) Launches AI-Powered Workforce Intelligence Platform via Lyneer ATLN Insider Monkey
May-29	Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes PFE Insider Monkey
May-29	Keros Therapeutics, Inc. (KROS) Halts PAH Drug Development After Safety Concerns in TROPOS Trial KROS Insider Monkey
May-29	Lantern Pharma Inc. (LTRN)'s LP-184 Shows 345% Survival Gain in Rare Pediatric Brain Tumor Models LTRN Insider Monkey
May-29	BioAge Labs, Inc. (BIOA)'s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025 BIOA Insider Monkey
May-29	Estrella Immunopharma, Inc. (ESLA) Doses First Patient in Higher-Dose Cohort of EB103 Phase I/II Trial ESLA Insider Monkey
May-29	Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests AZN DHR Insider Monkey
May-29	NextCure, Inc. (NXTC) and LCB to Unveil Promising Preclinical Data on B7-H4 ADC at AACR 2024 NXTC Insider Monkey
May-29	Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering REVB Insider Monkey
May-29	Regeneron Pharmaceuticals, Inc. (REGN) Licenses Gibson SOLA Platform to Boost R&D Efficiency REGN Insider Monkey
May-29	SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold SCYX Insider Monkey
May-29	AbbVie Inc. (ABBV)'s Pipeline Advances with Temab-A and ABBV-706, Shares Flat ABBV Insider Monkey
May-29	Biohaven Ltd. (BHVN)'s BHV-1400 Cuts Disease Antibody by 81% in IgA Nephropathy BHVN Insider Monkey
May-29	Taysha Gene Therapies, Inc. (TSHA)'s TSHA-102 Shows Promising Results in Rett Syndrome Patients Aged 6+ TSHA Insider Monkey
May-29	ORIC Pharmaceuticals, Inc. (ORIC) Secures $125M to Advance ORIC-944 Phase 3 Trials ORIC Insider Monkey
May-29	Veracyte, Inc. (VCYT) Presents Breakthrough Genomic Data to Predict Cancer Therapy Response at ASCO VCYT Insider Monkey
May-29	Neurocrine Biosciences, Inc. (NBIX)'s M4 Agonist Shows Promise in Schizophrenia Phase 2 Trial, Phase 3 Launched NBIX Insider Monkey
May-29	PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1 PEPG Insider Monkey
May-28	Alcon Inc. (ALC)'s TRYPTYR Wins FDA Nod for Dry Eye Disease ALC Insider Monkey
May-28	Imunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M More IMNN Insider Monkey
May-28	Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency ETON Insider Monkey
May-28	Fate Therapeutics, Inc. (FATE) Highlights Next-Gen iPSC Therapies for Autoimmune Diseases FATE Insider Monkey
May-28	Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut MRNA Insider Monkey
May-28	Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers GH Insider Monkey
May-27	MAIA Biotechnology, Inc. (MAIA) Raises $695K in Private Placement to Advance Cancer Trial MAIA Insider Monkey
May-27	Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408 TEVA Insider Monkey
May-27	Rocket Pharmaceuticals, Inc. (RCKT) Gene Therapy Trial Paused Following Patient Death RCKT Insider Monkey
May-27	Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal BIIB Insider Monkey
May-27	NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network NRXP Insider Monkey
May-27	Myriad Genetics, Inc. (MYGN) Showcases Breakthrough MRD Data and AI-Driven Cancer Tools at ASCO 2025 MYGN Insider Monkey
May-27	Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results ALUR Insider Monkey
May-24	FDA Approves Liquidia Corporation (LQDA)'s YUTREPIA Amid Patent Dispute LQDA Insider Monkey
May-24	Palantir Technologies Inc. (PLTR) CEO Sells $50M in Shares as Execs Also Cut Holdings PLTR Insider Monkey
May-23	Amazon.com, Inc. (AMZN)-Backed Anthropic Launches Claude 4, Its Most Advanced AI Yet AMZN Insider Monkey
May-23	PDS Biotechnology Corporation (PDSB)'s Versamune HPV Surpasses Survival Benchmarks in Recurrent Head and Neck Cancer Trial PDSB Insider Monkey
May-23	Soleno Therapeutics, Inc. (SLNO) Secures EMA Validation for PWS Treatment VYKAT XR SLNO Insider Monkey
May-23	Genmab A/S (GMAB) Unveils Promising Rina-S and Epcoritamab Data at ASCO 2025 GMAB Insider Monkey
May-23	Candel Therapeutics, Inc. (CADL) to Present Positive Phase 3 Prostate Cancer Data at ASCO 2025 CADL Insider Monkey
May-23	Amazon.com, Inc. (AMZN) Shareholders Overwhelmingly Reject Proposal to Permanently Split CEO and Chair Roles AMZN Insider Monkey
May-23	AbbVie Inc. (ABBV) Scores Major Legal Victory as Illinois Court Shuts Down $63 Billion Allergan Shareholder Lawsuit ABBV Insider Monkey
May-22	Dillard's, Inc. (DDS) Sues Wells Fargo Over Co-Branded Card Relationship DDS Insider Monkey
May-22	Build 2025 Chaos: Walmart Inc. (WMT)'s Powerful AI Tool 'MyAssistant' Unintentionally Revealed By MSFT MSFT WMT Insider Monkey
May-22	Apple Inc. (AAPL) Partners with Emory Healthcare to Power First U.S. Hospital with Its Devices AAPL Insider Monkey
May-22	UnitedHealth Group Incorporated (UNH) Faces Mounting Backlash Amid Billing Disputes, CEO Resignation, and Criminal Probe UNH Insider Monkey
May-22	Restaurant Brands International Inc. (QSR)'s Burger King Turns Up the Heat with Dragon Whopper and Family-First Marketing Blitz QSR Insider Monkey
May-22	Amazon.com, Inc. (AMZN) CEO Jassy Says Trump Tariffs Haven't Slowed Consumer Spending AMZN Insider Monkey
May-22	CSX Corporation. (CSX) Sees Growth as 600+ New Projects Ride Domestic Manufacturing Wave CSX Insider Monkey
May-22	Microsoft Corporation (MSFT) and Global Law Enforcement Dismantle Lumma Stealer Malware Network Infecting 394,000 Devices MSFT Insider Monkey
May-22	Hinge Health, Inc. (HNGE) Sets IPO Price at $32, Debuts on NYSE with $2.6 Billion Valuation HNGE Insider Monkey
May-20	CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug CRSP Insider Monkey
May-20	Johnson & Johnson (NYSE:JNJ) Hit with $147M Verdict in Landmark Antitrust Case Over Reprocessed Medical Devices JNJ Insider Monkey
May-09	Summit Therapeutics Inc. (SMMT): Among the Best Cancer Stocks to Invest in for Long-Term Gain SMMT Insider Monkey
May-09	Halozyme Therapeutics, Inc. (HALO): Among the Best Cancer Stocks to Invest in for Long-Term Gain HALO Insider Monkey
May-09	Celldex Therapeutics, Inc. (CLDX): Among the Best Cancer Stocks to Invest in for Long-Term Gain CLDX Insider Monkey
May-09	MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain MNKD Insider Monkey
May-09	Krystal Biotech, Inc. (KRYS): Among the Best Cancer Stocks to Invest in for Long-Term Gain KRYS Insider Monkey
May-09	TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain TGTX Insider Monkey
May-09	Protagonist Therapeutics, Inc. (PTGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain PTGX Insider Monkey
May-09	argenx SE (ARGX): Among the Best Cancer Stocks to Invest in for Long-Term Gain ARGX Insider Monkey
May-09	Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain MRUS Insider Monkey
May-09	Is Insmed Incorporated (INSM) One of the Best Cancer Stocks to Invest in for Long-Term Gain? INSM Insider Monkey
Jan-01	Candel Therapeutics, Inc. (CADL) to Present Positive Phase 3 Prostate Cancer Data at ASCO 2025 CADL Insider Monkey
Jan-01	Allurion Technologies Inc. (ALUR) Returns to France with 12.2% Weight Loss, 6.6% Muscle Gain Results ALUR Insider Monkey
Jan-01	NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Acquires Kadima Institute to Launch $100M Psychiatry Clinic Network NRXP Insider Monkey
Jan-01	Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal BIIB Insider Monkey
Jan-01	Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers GH Insider Monkey
Jan-01	CSX Corporation. (CSX) Sees Growth as 600+ New Projects Ride Domestic Manufacturing Wave CSX Insider Monkey
Jan-01	Fate Therapeutics, Inc. (FATE) Highlights Next-Gen iPSC Therapies for Autoimmune Diseases FATE Insider Monkey
Jan-01	Revelation Biosciences, Inc. (REVB) Raises $4M in Public Offering REVB Insider Monkey
Jan-01	BioAge Labs, Inc. (BIOA)'s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025 BIOA Insider Monkey
Jan-01	CRISPR Therapeutics AG (CRSP) Strikes $95M Deal with Sirius to Develop Blood Clot Drug CRSP Insider Monkey
Jan-01	SCYNEXIS, Inc. (SCYX) Resumes Phase III Dosing for Brexafemme After 19-Month FDA Hold SCYX Insider Monkey
Jan-01	Concord Medical Services Holdings Limited (CCM)'s Subsidiary Debuts Nation's First Proton Therapy LLM CCM Insider Monkey
Jan-01	Avadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025 AVDL Insider Monkey

Laiba Immad

Recent Articles by Laiba Immad

Upgrade your FINVIZ experience